Diagnostics Solutions Strategic Priorities
Key launches 2021
Area
Product
cobasⓇ pure integrated solutions
Core Lab
cobasⓇ pro integrated solutions
Point of Care cobas® pulse
Instruments
cobas® 5800
Molecular Lab
AVENIO Edge System
Diabetes Care Accu-Chek Instant
Core Lab
•
•
Tests
Molecular Lab
Pathology Lab
Ⓡ
Elecsys SARS-CoV-2 Antigen
ElecsysⓇ NT-proBNP IU
extensions in Heart Failure
extension for Atrial Fibrillation
ElecsysⓇ TnT-hs 3 claim extensions
in Coronary Arterial Disease
Description
Low-to-medium volume SWA
New high throughput configurations of the cobas pro instrument
Successor of Accu-ChekⓇ Inform II
Fully automated low throughput PCR system
Automated sequencing library preparation and target enrichment instrument
New features for the monitoring system to increase performance and user experience
Automated laboratory assay intended as an aid in the diagnosis of SARS-CoV-2 infection
A set of 5 intended use extensions in the Coronary Arterial Disease, Atrial Fibrillation and
Heart Failure Space
Decentralized kit of the Foundation One test
AVENIO FoundationOne kit (RUO)
New targeted sequencing portfolio using primer extension for small targets
KAPA HyperPETE kit
uPath 2.0
First IVD release and version of Open API of the clinical pathologist workflow module for
NAVIFY Digital Pathology & on-premise uPath
Roche
Market¹
CE
US & CE
CE
CE
WW
WW
US
CE
WW
WW
WW
Digital
Solutions
Insights
Core Lab
RUO Algorithms
NAVIFY Oncology 1.0
NAVIFY Pass 1.0
ElecsysⓇ GAAD Algorithm
Whole slide image analysis algorithms (ER (SP1), Ki-67 (30-9), and PR (1E2))
Modular Oncology decision support solution
WW
WW³
RocheDiabetes RemoteCare
Diabetes Care
Accu-Chek SugarView
Solution for providers to communicate SARS-CoV-2 rapid antigen test results to a mobile app
Algorithm for early detection of HCC in patients with chronic liver disease.
Module within the RocheDiabetes Care Platform enabling remote interactions between HCPs
and patients, including a patient dashboard, check-in and chat functionality
Meter-free blood glucose testing using a smartphone app and test strips
US & CE³
CE
WW³
OUS³
36
RDCP: Roche Diabetes Care Platform; 1 CE: European Conformity, US: FDA approval, WW: Worldwide, OUS: Outside the US; 2 Research Use Only; 3 Only a few selected countriesView entire presentation